Vitronectin (VTN-N) Recombinant Human Protein, truncated, 1 mL tube

The University of Virginia awarded contract A207_PO-0446462 to Life Technologies Corporation on June 8, 2026, for the supply of specialized biological materials. The contract encompasses the delivery of Vitronectin (VTN-N) Recombinant Human Protein, truncated formulation, provided in a 1 milliliter tube. The single line item quantity of one unit carries a unit price of $91.88, resulting in a cumulative contract value of $91.00. The deliverable is designated for receipt by Danielle Wuerdeman at the University of Virginia.

This procurement represents a direct purchase of research-grade protein products for use by the Virginia-based academic institution. Life Technologies Corporation, the prime contractor, was selected to fulfill this requirement for recombinant human protein materials. No information regarding an extended performance period or annual value separate from the total contract amount is available in the award documentation. The contract award reflects a single-item purchase transaction typical of university procurement activities for laboratory and research applications.